Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Tim L.
Tim holds an MA, MPhil, and PhD in English and Comparative Literature from Columbia University. He earned his Bachelor's in English and Classical Languages from the University of Nebraska-Lincoln.
King
King is currently an MD student at Harvard. He earned his BA in Sociology and Health from University Notre Dame, and earned a MS in Global Public Health and Policy at Queen Mary University of London.